Biopharmaceutical Analysis

Chalmers University researchers have developed a method to label and track mRNA molecules.

Thermo Fisher Scientific has introduced its new Quick to Clinic solution, which is designed to accelerate biologic drug development from discovery to the IND phase in a shortened period.

The CYTRIX Microfluidic Hydrogel Kit is the first in Sphere Fluidics’ new range of 3D cell culture kits in partnership with ClexBio.

The increased number of regulatory filings for cell and gene therapies requires reevaluation of bioassay methods because of their complexity.

PPD has opened its new multipurpose clinical research laboratory in Suzhou, China, which offers bioanalytical, biomarker, and vaccine sciences services for China and the global market.

The acquisition gives PerkinElmer access to Nexcelom Bioscience’s complementary cell counting and analysis capabilities and enhances its QA/QC capabilities.

The expected growth of the global bio/pharmaceutical market is pushing for the continued evolution of the CDMO arena.

Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.

Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.

A shortage of pipette tips has been attributed to several factors, including the COVID-19 pandemic.

Dynamic light scattering presents a good analytical technique for testing protein stability.

The need for real-time monitoring and control has spurred the development of new analytical tools.

Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.

The companies intend to design and implement algorithms for the early stages of research for drug discovery and development of drug candidates to treat Alzheimer’s disease.

The acquisition strategically expands SPT Labtech’s offering in sample management for life sciences.

Nexelis’ recent acquisition of GSK’s Marburg, Germany-based vaccines clinical bioanalytical laboratory expands its bioanalytical capabilities.

The £500,000 (US$686,294)-investment in mass spectrometry support will accelerate biologics development and approval.

Demand for specific advanced laboratory skills creates a positive employment market.

Using rDNA technology to synthesize production of proteins and peptide hormones, the biotech startup has achieved synthetic production of insulin, potentially lowering insulin cost by 30%.

After a hectic 2020, biopharma looks to deliver on COVID-19 vaccines and move other promising therapies forward.

Essential bio/pharma employees show hard work and dedication can pay off, for patients.

Clear understanding of what exactly the biomolecule entails is essential.

A novel PTA technology captures more than 95% of the genomes of single cells, providing more uniform, accurate, and reproducible single-cell analysis data.

Analytical and functional characterization of virus-like particles enables process reproducibility and product consistency.

Dolomite Microfluidics and MilliporeSigma have begun a collaboration to release off-the-shelf microfluidic device kits for the fabrication of PLGA particles.

The partners have established PathoQuest, Inc., a US subsidiary, and will construct an NGS-based testing lab at Charles River’s Wayne, PA, site.

The shift to single-use technologies is driving the need for innovation in PAT-friendly sensor technologies.

Early detection and more sensitive methods of detecting adventitious agents are becoming increasingly critical in bioprocessing.

Analysts should understand how a monograph, together with the associated general notices and general chapters, relate to their responsibilities under good manufacturing practices.

Current and newer biologic modalities pose increasingly complex challenges to the detection and characterization of protein aggregates.